William A. Hanlon

2.0k total citations · 1 hit paper
20 papers, 1.4k citations indexed

About

William A. Hanlon is a scholar working on Molecular Biology, Immunology and Allergy and Immunology. According to data from OpenAlex, William A. Hanlon has authored 20 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Immunology and Allergy and 6 papers in Immunology. Recurrent topics in William A. Hanlon's work include Cell Adhesion Molecules Research (7 papers), Parathyroid Disorders and Treatments (3 papers) and Cellular Mechanics and Interactions (3 papers). William A. Hanlon is often cited by papers focused on Cell Adhesion Molecules Research (7 papers), Parathyroid Disorders and Treatments (3 papers) and Cellular Mechanics and Interactions (3 papers). William A. Hanlon collaborates with scholars based in United States and Netherlands. William A. Hanlon's co-authors include Qiang Tian, Hongyue Dai, Bert Gunter, Joel P. Berger, David R. Goodlett, Vésteinn Thórsson, Jimmy K. Eng, Mao Mao, Leroy Hood and Roland Stoughton and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Immunology and Biochemistry.

In The Last Decade

William A. Hanlon

20 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Integrated Genomic and Proteomic Analyses of Gene Expression in Mammalian Cells

2004 647 citations Qiang Tian, Mao Mao et al. Molecular & Cellular Proteomics profile →

Peers

Countries citing papers authored by William A. Hanlon

Since Specialization

Citations

This map shows the geographic impact of William A. Hanlon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William A. Hanlon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William A. Hanlon more than expected).

Fields of papers citing papers by William A. Hanlon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William A. Hanlon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William A. Hanlon. The network helps show where William A. Hanlon may publish in the future.

Co-authorship network of co-authors of William A. Hanlon

This figure shows the co-authorship network connecting the top 25 collaborators of William A. Hanlon. A scholar is included among the top collaborators of William A. Hanlon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William A. Hanlon. William A. Hanlon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Extended-release niacin/laropiprant lowers serum phosphorus concentrations in patients with type 2 diabetes 2011 ·Journal of clinical lipidology ·Andrew G. Bostom, Alexandra A. MacLean, Darbie Maccubbin, Diane Tipping, Hilde Giezek, William A. Hanlon	9
2	Hypophosphatemic Effect of Niacin in Patients without Renal Failure 2010 ·Clinical Journal of the American Society of Nephrology ·Darbie Maccubbin, Diane Tipping, Olga Kuznetsova, William A. Hanlon, Andrew G. Bostom	42
3	Extended-Release Niacin/Laropiprant Lowers Serum Phosphorus Concentrations in Patients with Type 2 Diabetes and Mild Hyperphosphatemia 2010 ·Journal of clinical lipidology ·Andrew G. Bostom, Alexandra A. MacLean, Darbie Maccubbin, Diane Tipping, (unknown), William A. Hanlon	1
4	Discovery of 3,5-bis(trifluoromethyl)benzyl l-arylglycinamide based potent CCR2 antagonists 2006 ·Bioorganic & Medicinal Chemistry Letters ·Lihu Yang, Changyou Zhou, Liangqin Guo, Gregori J. Morriello, Gabor Butora, Alexander Pasternak, William H. Parsons, Sander G. Mills, Malcolm MacCoss, Pasquale P. Vicario, Hans J. Zweerink, Julia M. Ayala, Shefali Singla, William A. Hanlon, Margaret A. Cascieri, Marty S. Springer	20
5	Integrated Genomic and Proteomic Analyses of Gene Expression in Mammalian Cells breakdown → 2004 ·Molecular & Cellular Proteomics ·Qiang Tian, (unknown), Mao Mao, (unknown), (unknown), Michelle J. Doyle, Eugene C. Yi, Hongyue Dai, Vésteinn Thórsson, Jimmy K. Eng, David R. Goodlett, Joel P. Berger, Bert Gunter, (unknown), Roland Stoughton, Ruedi Aebersold, Steven Collins, William A. Hanlon, Leroy Hood	647
6	Expression and characterization of the chemokine receptor CCR2B from rhesus monkey 2003 ·Biochemical Pharmacology ·Hongjian Jin, Pasquale P. Vicario, Hans J. Zweerink, Shefali Singla, William A. Hanlon, Conrad P. Dorn, Sander G. Mills, Julie A. DeMartino, Margaret A. Cascieri, Mary Struthers	3
7	Toll-like receptor 2 (TLR2) mediates activation of stress-activated MAP kinase p38 2002 ·Journal of Leukocyte Biology ·Thierry Vasselon, William A. Hanlon, Samuel D. Wright, Patricia A. Detmers	46
8	L-Selectin Signaling of Neutrophil Adhesion and Degranulation Involves p38 Mitogen-activated Protein Kinase 2000 ·Journal of Biological Chemistry ·James E. Smolen, Thomas K. Petersen, Cody A. Koch, Stephen J. O’Keefe, William A. Hanlon, (unknown), David Pearson, (unknown), Scott I. Simon	122
9	Serum-induced monocyte differentiation and monocyte chemotaxis are regulated by the p38 MAP kinase signal transduction pathway 2000 ·Journal of Leukocyte Biology ·Julia M. Ayala, Shefali Singla, Nigel J. Liverton, (unknown), Stephen J. O’Keefe, William A. Hanlon	52
10	Enzymatically Inactive Macrophage Migration Inhibitory Factor Inhibits Monocyte Chemotaxis and Random Migration 1999 ·Biochemistry ·Anne Hermanowski‐Vosatka, Steven S. Mundt, Julia M. Ayala, Shefali Singla, William A. Hanlon, Robert Czerwiński, Samuel D. Wright, Christian P. Whitman	93
11	Role of stress-activated mitogen-activated protein kinase (p38) in beta 2-integrin-dependent neutrophil adhesion and the adhesion-dependent oxidative burst. 1998 ·PubMed ·P A Detmers, (unknown), (unknown), Rolf Thieringer, William A. Hanlon, (unknown), Vishal Bansal	106
12	Role of Stress-Activated Mitogen-Activated Protein Kinase (p38) in β2-Integrin-Dependent Neutrophil Adhesion and the Adhesion-Dependent Oxidative Burst 1998 ·The Journal of Immunology ·Patricia A. Detmers, (unknown), (unknown), Rolf Thieringer, William A. Hanlon, Sanskruti Vaidya, Vinay S. Bansal	97
13	Pkn9, a Ser/Thr protein kinase involved in the development of Myxococcus xanthus 1997 ·Molecular Microbiology ·William A. Hanlon, Masayori Inouye, Sumiko Inouye	50
14	Formation of polymorphonuclear leukocyte elastase: α1 proteinase inhibitor complex and Aα(1–21) fibrinopeptide in human blood stimulated with the calcium ionophore A23187 1995 ·Biochemical Pharmacology ·Stephen G Pacholok, Philip R. Davies, Conrad P. Dorn, Paul E. Finke, William A. Hanlon, Richard A. Mumford, John L. Humes	10
15	Phosphorous acid analogs of L-680,833, a potent monocyclic β-lactam inhibitor of human leukocyte elastase 1995 ·Bioorganic & Medicinal Chemistry Letters ·Philippe L. Durette, Renee M. Chabin, Daniel S. Fletcher, Barbara G. Green, William A. Hanlon, John L. Humes, Wilson B. Knight, Thomas J. Lanza, Richard A. Mumford, Stephen G Pacholok, Malcolm MacCoss	5
16	MlpA, a lipoprotein required for normal development of Myxococcus xanthus 1995 ·Journal of Bacteriology ·William A. Hanlon, Magdalena Martínez‐Cañamero, Masayori Inouye, S Inouye	4
17	Potency of Antileukoprotease and α 1-Antitrypsin to Inhibit Degradation of Fibrinogen by Adherent Polymorphonuclear Leukocytes from Normal Subjects and Patients with Chronic Granulomatous Disease 1992 ·American Journal of Respiratory Cell and Molecular Biology ·Jan Stolk, Philip R. Davies, Johannes A. Kramps, Joop H. Dijkman, (unknown), Wilson B. Knight, Barbara G. Green, Richard A. Mumford, Robert J. Bonney, William A. Hanlon	8
18	Direct Assay of Aα(1–21), a PMN Elastase‐Specific Cleavage Product of Fibrinogen, in the Chimpanzee 1991 ·Annals of the New York Academy of Sciences ·Richard A. Mumford, (unknown), (unknown), Mary Ellen Dahlgren, (unknown), (unknown), (unknown), James B. Doherty, Daniel S. Fletcher, (unknown), Robert J. Bonney, John L. Humes, Stephen G Pacholok, William A. Hanlon, Philip R. Davies	8
19	The Discovery and Biologic Properties of Cephalosporin‐Based Inhibitors of PMN Elastase 1991 ·Annals of the New York Academy of Sciences ·Philip R. Davies, Bonnie M. Ashe, Robert J. Bonney, Conrad P. Dorn, Paul E. Finke, D. Fletcher, William A. Hanlon, John L. Humes, Alan L. Maycock, Richard A. Mumford, Manuel A. Navia, Evan E. Opas, Stephen G Pacholok, (unknown), M.D. Zimmerman, James B. Doherty	24
20	rTNFα Facilitates Human Polymorphonuclear Leukocyte Adherence to Fibrinogen Matrices With Mobilization of Specific and Tertiary but Not Azurophilic Granule Markers 1991 ·Journal of Leukocyte Biology ·William A. Hanlon, Jan Stolk, Philip R. Davies, John L. Humes, Richard A. Mumford, Robert J. Bonney	44

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact